| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1885 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 304 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 183 | 2021 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 142 | 2020 |
| Characterization of KRAS mutation subtypes in non–small cell lung cancer J Judd, N Abdel Karim, H Khan, AR Naqash, Y Baca, J Xiu, ... Molecular cancer therapeutics 20 (12), 2577-2584, 2021 | 104 | 2021 |
| Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes H Khan, C Vale, T Bhagat, A Verma Seminars in hematology 50 (1), 16-37, 2013 | 84 | 2013 |
| Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations JH Starrett, AA Guernet, ME Cuomo, KE Poels, ... Cancer research 80 (10), 2017-2030, 2020 | 63 | 2020 |
| Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis M Tsikala-Vafea, N Belani, K Vieira, H Khan, D Farmakiotis International Journal of Infectious Diseases 106, 142-154, 2021 | 56 | 2021 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 50 | 2022 |
| Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases L Jia, MI Carlo, H Khan, GJ Nanjangud, S Rana, R Cimera, Y Zhang, ... Modern Pathology 32 (9), 1329-1343, 2019 | 49 | 2019 |
| Role of vitamins C and E in regulating antioxidant and pro-oxidant markers in preeclampsia M Suhail, MF Suhail, H Khan Journal of clinical biochemistry and nutrition 43 (3), 210-220, 2008 | 44 | 2008 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 42 | 2021 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 34 | 2023 |
| Testosterone levels and quality of life in diverse male patients with cancers unrelated to androgens SB Fleishman, H Khan, P Homel, MF Suhail, R Strebel-Amrhein, ... Journal of clinical oncology 28 (34), 5054-5060, 2010 | 32 | 2010 |
| Evolving concepts: immunity in oncology from targets to treatments H Khan, R Gucalp, I Shapira Journal of oncology 2015 (1), 847383, 2015 | 30 | 2015 |
| Pancreatoblastoma: a rare tumor still evolving in clinical presentation and histology C Balasundaram, M Luthra, D Chavalitdhamrong, J Chow, H Khan, ... JOP. Journal of the Pancreas 13 (3), 301-303, 2012 | 27 | 2012 |
| Alterations in antioxidant and pro-oxidant balance in preeclampsia–impact on erythrocyte osmotic fragility M Suhail, MF Suhail, H Khan Biochemia Medica 18 (3), 331-341, 2008 | 27 | 2008 |
| Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium A Elkrief, C Hennessy, NM Kuderer, SM Rubinstein, E Wulff-Burchfield, ... The Lancet Healthy Longevity 3 (3), e143-e152, 2022 | 22 | 2022 |
| A definitive prognostication system for patients with thoracic malignancies diagnosed with coronavirus disease 2019: an update from the TERAVOLT registry JG Whisenant, J Baena, A Cortellini, LC Huang, GL Russo, L Porcu, ... Journal of Thoracic Oncology 17 (5), 661-674, 2022 | 19 | 2022 |
| A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ... Cancer Cell 38 (6), 761-766, 2020 | 18 | 2020 |
